Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Changes in Stockholders' Equity (Deficit) (Unaudited)

v3.25.1
Condensed Consolidated Statements of Changes in Stockholders' Equity (Deficit) (Unaudited) - USD ($)
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
At-The-Market Financing
At-The-Market Financing
Common Stock
At-The-Market Financing
Additional Paid-In Capital
Private Placement Offering
Private Placement Offering
Common Stock
Private Placement Offering
Additional Paid-In Capital
Private Placement Offering 1
Private Placement Offering 1
Common Stock
Private Placement Offering 1
Additional Paid-In Capital
Private Placement Offering 2
Private Placement Offering 2
Common Stock
Private Placement Offering 2
Additional Paid-In Capital
Balance at Dec. 31, 2023 $ 477,511 $ 1,699 $ 64,472,249 $ (63,980,177) $ (16,260)                        
Balance, Shares at Dec. 31, 2023   16,986,254                              
Issuance of restricted stock 11,500 $ 1 11,499                            
Issuance of restricted stock, Shares   12,500                              
Stock-based compensation expense 349,965   349,965                            
Issuance of common shares           $ 565,623 $ 51 $ 565,572       $ 590,411 $ 250 $ 590,161 $ 90,618 $ 58 $ 90,560
Issuance of common shares, Shares             507,754           2,496,318     578,643  
Issuance of warrants in connection                       $ 230,685   $ 230,685      
Foreign currency translation adjustment (13,786)       (13,786)                        
Net loss (8,067,455)     (8,067,455)                          
Balance at Mar. 31, 2024 (5,764,928) $ 2,059 66,310,691 (72,047,632) (30,046)                        
Balance, Shares at Mar. 31, 2024   20,581,469                              
Balance at Dec. 31, 2024 3,634,636 $ 2,616 90,897,468 (87,234,833) (30,615)                        
Balance, Shares at Dec. 31, 2024   26,157,788                              
Exercise of stock options $ 844   844                            
Exercise of stock options, shares 570 570                              
Stock-based compensation expense $ 371,472   371,472                            
Issuance of common shares           $ 1,390,871 $ 67 $ 1,390,804 $ 2,390,733 $ 276 $ 2,390,457            
Issuance of common shares, Shares             666,323     2,762,633              
Issuance of warrants in connection                 $ 1,678,768   $ 1,678,768            
Foreign currency translation adjustment (7,540)       (7,540)                        
Net loss (4,517,259)     (4,517,259)                          
Balance at Mar. 31, 2025 $ 4,942,525 $ 2,959 $ 96,729,813 $ (91,752,092) $ (38,155)                        
Balance, Shares at Mar. 31, 2025   29,587,314